glp 1 cirrhosis Why are GLP-1 agonists being used to treat patients with nonalcoholic fatty liver disease? GLP-1 Receptor Agonists and Risk

In June 2020, at the American Diabetes Association conference, Pfizer first publicly disclosed clinical Phase I study data on its GLP-1R agonist PF-06882961 for the treatment of diabetes

It promotes weight loss by slowing the emptying of the stomach, signaling fullness to the brain, lessening feelings of hunger, and increasing the bodys insulin production

If you dont have a clinician you feel is knowledgeable about GLP-1s and HT, consider Midi Health or Alloy Health as options for one or both

Pros: No Side effects except I was gassy and bloated during the first week or so but that went away

This is something I talk about often: health begins at the cellular level, and healthy mitochondria are at the heart of that process